A carregar...
CAR T-cell Therapy for Pancreatic Cancer
Chimeric antigen receptor (CAR) T-cell therapy utilizes genetic engineering to redirect a patient’s own T cells to target cancer cells. The remarkable results in hematological malignancies prompted investigating this approach in solid tumors such as pancreatic cancer. The complex tumor microenvironm...
Na minha lista:
Publicado no: | J Surg Oncol |
---|---|
Main Authors: | , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5491361/ https://ncbi.nlm.nih.gov/pubmed/28346697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jso.24627 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|